119-hres419

HRES
✓ Complete Data

Expressing support for the designation of May 17, 2025, as "DIPG Awareness Day" to raise awareness and encourage research into cures for diffuse intrinsic pontine glioma (DIPG) and pediatric cancers in general.

Login to track bills
Introduced:
May 15, 2025
Policy Area:
Health

Bill Statistics

3
Actions
10
Cosponsors
0
Summaries
1
Subjects
1
Text Versions
Yes
Full Text

AI Summary

No AI Summary Available

Click the button above to generate an AI-powered summary of this bill using Claude.

The summary will analyze the bill's key provisions, impact, and implementation details.

Latest Action

May 15, 2025
Referred to the House Committee on Energy and Commerce.

Actions (3)

Referred to the House Committee on Energy and Commerce.
Type: IntroReferral | Source: House floor actions | Code: H11100
May 15, 2025
Submitted in House
Type: IntroReferral | Source: Library of Congress | Code: H11100
May 15, 2025
Submitted in House
Type: IntroReferral | Source: Library of Congress | Code: 1025
May 15, 2025

Subjects (1)

Health (Policy Area)

Text Versions (1)

Introduced in House

May 15, 2025

Full Bill Text

Length: 3,054 characters Version: Introduced in House Version Date: May 15, 2025 Last Updated: Nov 10, 2025 6:15 AM
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 419 Introduced in House

(IH) ]

<DOC>

119th CONGRESS
1st Session
H. RES. 419

Expressing support for the designation of May 17, 2025, as ``DIPG
Awareness Day'' to raise awareness and encourage research into cures
for diffuse intrinsic pontine glioma

(DIPG) and pediatric cancers in
general.

_______________________________________________________________________

IN THE HOUSE OF REPRESENTATIVES

May 15, 2025

Mrs. Dingell (for herself, Mr. Joyce of Ohio, Mr. McCaul, Mr. Cohen,
Mr. Quigley, Mr. McGovern, and Ms. Castor of Florida) submitted the
following resolution; which was referred to the Committee on Energy and
Commerce

_______________________________________________________________________

RESOLUTION

Expressing support for the designation of May 17, 2025, as ``DIPG
Awareness Day'' to raise awareness and encourage research into cures
for diffuse intrinsic pontine glioma

(DIPG) and pediatric cancers in
general.

Whereas diffuse intrinsic pontine glioma

(DIPG) affects 200 to 400 children in
the United States each year with certain regularity;
Whereas brain tumors are the leading cause of cancer-related death in children;
Whereas DIPG is the second most common malignant brain tumor of childhood;
Whereas DIPG is the leading cause of childhood death due to brain tumors;
Whereas the median survival time of an individual with DIPG is only 9 months
postdiagnosis with treatment;
Whereas 5-year survival of an individual with DIPG is less than 1 percent;
Whereas, given the age at diagnosis and the average life expectancy, the number
of life years lost annually because of DIPG is approximately 24,000
years of person life lost (calculated as the number of children
diagnosed by average of male and female life expectancy from that median
age, 300 x 80 = 24,000 years of person life lost annually);
Whereas prognosis has not improved for children with DIPG in over 40 years; and
Whereas Federal funding for research for pediatric cancer should be increased to
address the level of unmet medical need for this vulnerable population:
Now, therefore, be it
Resolved, That the House of Representatives--

(1) supports the designation of ``DIPG Awareness Day'';

(2) encourages all people of the United States to become
more informed about diffuse intrinsic pontine glioma

(DIPG) pediatric brain cancer, and the current challenges to the
medical research system in designating sufficient research
funding for pediatric cancers;

(3) supports expanded research to better understand DIPG,
develop effective treatments, and provide comprehensive care
for children with DIPG and their families; and

(4) encourages public and private sources of research
funding to elevate their consideration of the mortality rate of
a type of cancer, as well as the life-years lost, as
significant factors to be considered during the grant
application process.
<all>